Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations - Veneris, Jennifer Taylor; Matulonis, Ursula A.; Liu, Joyce F.; Konstantinopoulos, Panagiotis A. (Gynecologic oncology, 2020)
Keywords: Animals; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; BRCA1 Protein - genetics; BRCA2 Protein - genetics; Developmental therapeutics; DNA damage repair; DNA Repair; Female; Genes, BRCA1; Genes, BRCA2; Germ-Line Mutation; Hematology, Oncology, and Palliative Medicine; Humans; Obstetrics and Gynecology; Ovarian cancer; Ovarian Neoplasms - drug therapy; Ovarian Neoplasms - genetics; Ovarian Neoplasms - immunology; PARP inhibitors; Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage; Randomized Controlled Trials as Topic; DNA damage repair; PARP inhibitors; Developmental therapeutics; Ovarian cancer